²úÆ·ÖÐÐÄ
ţϸ°ûÉ«ËØP4502E1(CYP2E1£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ðļ¡ÌØÒìÐÔ¼¡¸Æµ°°×T(cTnT£©ELISA¼ì²âÊÔ¼ÁºÐ
ţп½ðÊôÁòµ°°×(Zn-MT£©ELISA¼ì²âÊÔ¼ÁºÐ
ţѪ¹ÜÄÚÆ¤Ï¸°ûÉú³¤Òò×Ó(VEGF£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£×é°·(HIS£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£×éÖ¯¶àëÄ¿¹Ô(TPA£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£×éÖ¯ÐÍÏËÈÜøԼ¤»î¼Á(t-PA£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÈýÁ×ËáÏÙÜÕ(ATP£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£¶þÁ×ËáÏÙÜÕ(ADP£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÑÌõ£°·ÏÙàÑßʶþºËÜÕËáÁ×Ëá(NADPH£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÑÌõ£°·ÏÙàÑßʶþºËÜÕËá(NAD£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£NADH(NADH£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£½áºË²¡(TB£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÑÌõ£°·ÏÙàÑßʶþºËÜÕËáÁ×Ëá(NADP£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£ÔØÖ¬µ°°×C3(apo-C3£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Õ³µ°°×1(MUC1£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ö¬µ°°×֬ø(LPL£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ö¬¶àÌÇ(LPS£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ö¬¶àÌǽáºÏµ°°×(LBP£©ELISA¼ì²âÊÔ¼ÁºÐ
Å£Ö¬·¾Ã¸(Lipase£©ELISA¼ì²âÊÔ¼ÁºÐ
Ò³´Î12/15 ÿҳ20Ìõ ×ܹ²286Ìõ Ê×Ò³ÉÏÒ»Ò³ÏÂһҳβҳ
µÚ7Äê